| Global Managing Partner |
Accenture |
| Principal |
Advanced Technology Ventures |
| Head of Translational Research |
Albert Einstein College of Medicine |
| Vice President |
Alexandria |
| President & CEO |
Allozyne |
| President & CEO |
Altus Pharmaceuticals |
| Sr. Vice President |
AMAG Pharmaceuticals |
| President |
American Radiolabeled Chemicals |
| Head of Discovery Research |
Amgen |
| Chairman & CEO |
AMRI |
| Managing Director |
APC Pharmaceuticals |
| President & CEO |
Aphios Corporation |
| Vice President- Cancer Discovery |
AstraZeneca |
| Director- Licensing & Scientific Affairs |
Astrazeneca Pharmaceuticals |
| Chief Executive Officer |
Aurigene Discovery |
| President & CEO |
BIND Biosciences |
| Senior Vice President- Strategy |
Biogen Idec |
| Sr. Vice President-Neurology R&D |
Biogen Idec |
| Sr. Vice President- Immunology R&D |
Biogen Idec |
| President & CEO |
Biogen Idec |
| Executive Vice President |
Biotechnology Industry Organization |
| Partner |
Boston Millennia Partners |
| Executive Director |
Boston University |
| Director- Karp Lab. |
Brigham and Women's Hospital |
| Scientific Director |
Brigham and Women's Hospital |
| Managing Director |
Bristol-Myers Squibb |
| Vice President- R&D Finance |
Bristol-Myers Squibb |
| Director- Chemical Biology Program |
Broad Institute |
| Associate Provost |
BU School of Public Health |
| Chief Scientific Officer |
Catabasis Pharmaceuticals |
| Director |
Center for Connected Health |
| Exe. Vice President |
Charles River |
| President & CEO |
CombinatoRx |
| Treasurer & Receiver General |
Commonwealth of Massachusetts |
| Managing Director |
CRT Investment Banking |
| Associate Professor |
Dana-Farber Cancer Institute |
| Joint Secretary |
Department of Pharmaceuticals |
| Executive Director |
Duke University |
| Founder & Chairman |
Ecron Acunova |
| Vice President- Discovery Research |
Eli Lilly and Company |
| Vice President- Global External R&D |
Eli Lilly and Company |
| Assistant Managing Editor |
Elsevier Business Intelligence |
| Global Biotechnology Leader |
Ernst & Young |
| Managing Director |
Evolva Biotech |
| General Partner |
Extera Partners |
| Chief Executive Officer |
First Stop Urgent Care PSC |
| Managing Partner & CEO |
Flagship Ventures |
| Managing Director |
Galen Partners |
| Chairman & CEO |
Gene Network Sciences |
| President & CEO |
GENETIX Pharmaceuticals |
| Chief Executive Officer |
Gennova Biopharmaceuticals |
| Chief Scientific Officer |
Genzyme |
| Senior Vice President |
Genzyme |
| Founder |
Gilliam Capital |
| President |
GVK BIOsciences |
| Distinguished Service Professor |
Harvard School of Public Health |
| Partner & Managing Director |
Health Advances |
| Chief Scientific Officer |
Helicos BioSciences |
| President & CEO |
Idera Pharmaceuticals |
| Founder & CEO |
Imperial Life Sciences |
| Chief Executive Officer |
Inno Bio Ventures Sdn. Bhd |
| President |
ISL INC. |
| Chief Executive Officer |
I-Therapeutix |
| Vice President |
Johnson & Johnson |
| Chief Executive Officer |
Jubilant Biosys |
| Executive Director |
Koch Institute, MIT |
| Chief of Arthroscopic Surgery |
Mass General Hospital |
| Professor of Tumor Biology |
Massachusetts General Hospital |
| Partner |
McKinsey & Company |
| Exe. Director- External Research |
Merck & Co. |
| Director |
Millipore |
| Professor of Immunology |
MIT |
| Director |
MIT- Technology Licensing Office |
| Managing Director |
New Leaf Venture Partners |
| Chief Financial Officer |
Novartis Oncology |
| Managing Director |
Novartis Option Fund |
| Managing Director |
Novartis Venture Fund |
| Chief Executive Officer |
Ocimum Biosolutions |
| Executive Director |
Office of Tech Dev, BU |
| Vice President and GM |
Orchid & Bexel BioPharma |
| Dy. Managing Director |
Orchid Chemicals & Pharmaceuticals |
| Senior Partner |
Orion Healthcare Equity Partners |
| Senior Associate Provost |
OTD, Harvard University |
| Managing General Partner |
Oxford Bioscience Partners |
| Senior Vice President |
Pall Corporation |
| Senior Vice President |
Pappas Ventures |
| Chief Strategy Officer |
Partners Harvard Medical Int. |
| Executive Director |
Partners Healthcare International |
| President- Global R&D |
Pfizer |
| Chief Medical Officer |
Philips Healthcare |
| General Partner |
Polaris Venture |
| Principal |
Radius Ventures |
| President & CEO |
Reliance Life Sciences |
| Co Leader- Global Stem Cell Initiative |
Sanofi Aventis |
| Site Head |
sanofi pasteur |
| Sr. Vice President & CSO |
Schering-Plough Research Institute |
| Managing Director & CFO |
Semler Research Center |
| Sr. Vice President |
State Street |
| Chairman & CEO |
Suven Life Sciences |
| Chief Operating Officer |
Syngene International |
| Chief Operating Officer |
Thermo Fisher Scientific |
| Partner |
Third Rock Ventures |
| Dean of Medical School |
Tufts University |
| Director- Gene Therapy Center |
Umass Medical School |
| President |
UMS Advisory |
| Vice President |
Vertex Pharmaceuticals |
| Managing Director |
VIMAC Ventures |
| President & CEO |
Waltham Technologies |
| Dy. Managing Director |
Wanbury Limited |
| Vice President |
Wyeth |
| Noble Laureate & Prof. |
Yale University |
